Cutaneous adverse drug reactions to allopurinol: 10 year observational survey of the dermatology department - Cagliari University (Italy)

The DRESS Syndrome: A Literature Review

(2011) Patrice Cacoub et al.   AMERICAN JOURNAL OF MEDICINE

Toxic epidermal necrolysis and Stevens-Johnson syndrome

(2011) Thomas Harr et al.   Orphanet Journal of Rare Diseases

Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

(2010) Wen-Hung Chung et al.   ALLERGOLOGY INTERNATIONAL

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

(2009) Wichittra Tassaneeyakul et al.   Pharmacogenetics and Genomics

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout

(2009) Jeannie Chao et al.   Current Rheumatology Reports

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

(2007) Sima Halevy et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

(2007) Jürgen Schneck et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY